Shanmuga Hospital Ltd

Key update

• AGM on 18 Sep 2026 approved increase in Authorised Share Capital and MOA amendment.
• Increase from Rs 14 crore to Rs 25 crore; shares from 1.40 crore to 2.50 crore.
• Subject to ROC approval; MOA clause V to be amended accordingly.
• No immediate fundraising or equity issuance disclosed.

Secretarial Auditor Appointment

• Appointment of CS S Anuradha as Secretarial Auditor.
• Term: five consecutive financial years from 2026-27 to 2030-31.
• Effective from April 1, 2026.
• Approved at AGM held 18 September 2026.
• Reason for change: appointment.
• Brief profile: over 25 years in corporate secretarial services.
• Disclosure of relationships with directors: Nil.
• Impact on board/committee composition: not stated.

AGM details

• AGM held on 18 Sep 2026 at 2:30 PM via VC/OAVM.
• Remote e-voting from 15–17 Sep 2026 and AGM voting conducted.
• Record date: 11 Sep 2026.

Resolutions and outcomes

• Ordinary: Receive and adopt audited financial statements and board reports.
• Ordinary: Re-appoint director by rotation.
• Ordinary: Re-appoint another director by rotation.
• Special: Approve subsequent alteration of capital and Memorandum of Association.
• Special: Alteration of Articles of Association.
• Ordinary: Grant ESOP for employees under SHANMUGA HOSPITAL 2026 plan.
• Ordinary: Appoint Company Secretary for five years.
• All resolutions approved by requisite majority; no material dissent.

AGM details

• Date/time: 18 Sep 2026, 2:30 PM IST.
• Mode: VC/OAVM; meeting concluded 2:46 PM IST.
• Cut-off for e-voting: 11 Sep 2026.
• Remote e-voting window: 15–17 Sep 2026.

Key resolutions and outcomes

• Adopt audited financial statements for year ended Mar 31, 2026; outcome pending.
• Re-appoint director retiring by rotation; outcome pending.
• Re-appoint another director retiring by rotation; outcome pending.
• Increase authorised share capital and alter MOA; outcome pending.
• Amend Main Object Clause of MOA; outcome pending.
• Alter Articles of Association; outcome pending.
• Grant ESOPs under 2026 plan; outcome pending.
• Appoint CS Anuradha as Secretarial Auditor for five years; outcome pending.

Director changes

• Directors retiring by rotation to be re-appointed.

Auditor appointments

• Secretarial Auditor appointed for five-year term 2026-31.

Financial highlights

• Revenue from operations: ₹4,743.61 Lakhs (FY2025-26).
• Total Income: ₹4,806.32 Lakhs.
• PAT: ₹421.06 Lakhs.
• EBITDA: ₹885.42 Lakhs.
• Basic EPS: ₹3.09.
• Net worth: ₹4,250.19 Lakhs.
• ROCE: 12.01%.
• IPO proceeds fully utilised; robotics funding completed.

Operations & clinical metrics

• In-patient admissions: 4,593; Out-patient visits: 44,898.
• Da Vinci Xi robotic system operationalised in 2025.
• Robotic surgeries: 100+; Surgeries performed: 2.5K+.
• Average length of stay: 2.6 days.

Technology & capabilities

• Investments in oncology, imaging and robotic technologies.
• Barriers to entry in robotics mitigated via Da Vinci Xi rollout.
• Shanmuga360 digital health platform under development to integrate services.

Capital structure & liquidity

• Authorised share capital: ₹14.00 Cr; issued: ₹13.613 Cr.
• Short-term borrowings: ₹314.43 Lakhs; Long-term borrowings: ₹359.35 Lakhs.
• Cash & bank balances: ₹192.52 Lakhs.
• IPO proceeds: ₹2,061.72 Lakhs; fully utilised.

Governance & compliance

• Board includes MD, EDs, and Independent Directors; AGM on 18 Sep 2026 via VC/OAVM.
• CS Anjana Anjan Maragatham appointed Secretarial Auditor for five years.
• Secretarial audit: no qualifications; governance processes robust.
• PoSH awareness training conducted; no complaints in FY2025-26.

ESG & CSR

• CSR obligation: ₹12.87 Lakhs; spent ₹12.94 Lakhs in FY25-26.
• CSR focus: education, healthcare, community development.
• Projects: Salem Ex-Servicemen Welfare Trust; Shanmuga Medical Research Foundation; Travellers Inn.
• Environmental initiatives: STP, Solar Power Plant, Biogas Plant.

Outlook & risks

• Healthcare growth in India expected 10-12% CAGR.
• Salem region presents expansion opportunities in tertiary care.
• Risks: regulatory shifts, inflation, talent retention, cybersecurity.

AGM Details

• AGM date 18 September 2026, 02:30 PM IST.
• Mode: VC/OAVM.
• Record/e-voting date: 11 September 2026.

Ordinary Business

• Adopt Audited Financial Statements for year ended 31 March 2026.
• Re‑appoint Mrs. Panneerselvam Jayalakshmi as Director.
• Re‑appoint Mr. Karuppiah Saravanan as Director.

Special Business

• Increase authorised share capital and amend MOA.
• Amend MOA main object to add two new clauses.
• Alter Articles: Definitions and capital/rights framework.
• Approve ESOP 2026 plan for up to 3.5 lakh options.
• Appoint CS Anuradha as Secretarial Auditor for five years.

Director Re‑appointments

• Mrs. Panneerselvam Jayalakshmi seeks re-appointment; retires by rotation.
• Mr. Karuppiah Saravanan seeks re-appointment; retires by rotation.